Cargando…
A pan-cancer analysis of the oncogenic role of dual-specificity tyrosine (Y)-phosphorylation- regulated kinase 2 (DYRK2) in human tumors
Although there have been studies correlating DYRK2 with a number of human cancers, there has been no pan-cancer analysis. Therefore, through the TCGA database, we conducted a related study on the expression of DYRK2 in cancers.The expression of DYRK2 is obviously increased in some cancers, while the...
Autores principales: | Qiu, Xinyue, Shen, Cheng, Zhao, Wenjing, Zhang, Xunlei, Zhao, Dakun, Wu, Xuming, Yang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474874/ https://www.ncbi.nlm.nih.gov/pubmed/36104345 http://dx.doi.org/10.1038/s41598-022-19087-7 |
Ejemplares similares
-
Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer
por: Yan, Haiyan, et al.
Publicado: (2016) -
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
por: Lindberg, Mattias F., et al.
Publicado: (2021) -
Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases
por: Correa-Sáez, Alejandro, et al.
Publicado: (2020) -
Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma
por: Uhl, Katie L., et al.
Publicado: (2018) -
Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy: DYRK2 is associated with survival in bladder cancer
por: Nomura, Shunichiro, et al.
Publicado: (2015)